Kazia Therapeutics Statistics
Total Valuation
KZIA has a market cap or net worth of $5.06 million. The enterprise value is $4.99 million.
| Market Cap | 5.06M |
| Enterprise Value | 4.99M |
Important Dates
The next estimated earnings date is Tuesday, July 9, 2024, before market open.
| Earnings Date | Jul 9, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
KZIA has 23.63 million shares outstanding.
| Shares Outstanding | 23.63M |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 1.26% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 323.64 |
| Forward PS | n/a |
| PB Ratio | 1.44 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 318.97 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.71, with a Debt / Equity ratio of 0.66.
| Current Ratio | 0.71 |
| Quick Ratio | 0.65 |
| Debt / Equity | 0.66 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -186.40% and return on invested capital (ROIC) is -222.13%.
| Return on Equity (ROE) | -186.40% |
| Return on Assets (ROA) | -60.10% |
| Return on Capital (ROIC) | -222.13% |
| Revenue Per Employee | $1,739 |
| Profits Per Employee | -$1.19M |
| Employee Count | 9 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -180,772 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -81.53% in the last 52 weeks. The beta is 2.05, so KZIA's price volatility has been higher than the market average.
| Beta (5Y) | 2.05 |
| 52-Week Price Change | -81.53% |
| 50-Day Moving Average | 0.28 |
| 200-Day Moving Average | 0.43 |
| Relative Strength Index (RSI) | 40.65 |
| Average Volume (20 Days) | 203,452 |
Short Selling Information
| Short Interest | 23,749 |
| Short Previous Month | 26,536 |
| Short % of Shares Out | 0.12% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.15 |
Income Statement
In the last 12 months, KZIA had revenue of $15,650 and -$10.68 million in losses. Loss per share was -$0.37.
| Revenue | 15,650 |
| Gross Profit | 15,346 |
| Operating Income | -12.92M |
| Pretax Income | -10.66M |
| Net Income | -10.68M |
| EBITDA | n/a |
| EBIT | -10.66M |
| Loss Per Share | -$0.37 |
Balance Sheet
The company has $2.38 million in cash and $2.30 million in debt, giving a net cash position of $73,134 or $0.00 per share.
| Cash & Cash Equivalents | 2.38M |
| Total Debt | 2.30M |
| Net Cash | 73,134 |
| Net Cash Per Share | $0.00 |
| Equity (Book Value) | 3.51M |
| Book Value Per Share | 0.15 |
| Working Capital | -2.22M |
Cash Flow
| Operating Cash Flow | -8.46M |
| Capital Expenditures | n/a |
| Free Cash Flow | -8.46M |
| FCF Per Share | -$0.37 |
Margins
Gross margin is 98.06%, with operating and profit margins of -82,565.33% and -68,255.35%.
| Gross Margin | 98.06% |
| Operating Margin | -82,565.33% |
| Pretax Margin | -68,084.34% |
| Profit Margin | -68,255.35% |
| EBITDA Margin | n/a |
| EBIT Margin | -68,084.34% |
| FCF Margin | -54,066.54% |
Dividends & Yields
KZIA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -72.73% |
| Shareholder Yield | -72.73% |
| Earnings Yield | -210.90% |
| FCF Yield | -167.06% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on July 14, 2017. It was a reverse split with a ratio of 1:4.
| Last Split Date | Jul 14, 2017 |
| Split Type | Reverse |
| Split Ratio | 1:4 |
Scores
KZIA has an Altman Z-Score of -7.71 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -7.71 |
| Piotroski F-Score | 1 |